Jake P Levy1, Maryam Oskoui1, Pamela Ng1, John Andersen1, David Buckley1, Darcy Fehlings1, Adam Kirton1, Louise Koclas1, Nicole Pigeon1, Esias van Rensburg1, Ellen Wood1, Michael Shevell1. 1. Faculty of Medicine (JPL), McGill University, Montreal, QC; Department of Pediatrics and Neurology and Neurosurgery (MO, MS), McGill University, Montreal, QC; Centre for Outcomes Research and Evaluation (MO, PN, MS), Research Institute of the McGill University Health Centre, Montreal, QC; Department of Pediatrics (JA), University of Alberta, Edmonton, AB; Janeway Children's Hospital (DB), St. John's, NL; Department of Paediatrics (DF), University of Toronto, Bloorview Research Institute, Toronto, ON; Departments of Pediatrics and Clinical Neurosciences (AK), Cumming School of Medicine, University of Calgary, AB; Centre de réadaptation Marie Enfant du CHU Sainte-Justine (LK), Montreal, QC; Centre hospitalier universitaire de Sherbrooke (NP), Sherbrooke, QC; BC Children's Hospital (EvR), Vancouver, BC; and IWK Health Centre (EW), Halifax, NS, Canada.
Abstract
OBJECTIVE: To specifically report on ataxic-hypotonic cerebral palsy (CP) using registry data and to directly compare its features with other CP subtypes. METHODS: Data on prenatal, perinatal, and neonatal characteristics and gross motor function (Gross Motor Function Classification System [GMFCS]) and comorbidities in 35 children with ataxic-hypotonic CP were extracted from the Canadian Cerebral Palsy Registry and compared with 1,804 patients with other subtypes of CP. RESULTS: Perinatal adversity was detected significantly more frequently in other subtypes of CP (odds ratio [OR] 4.3, 95% confidence interval [CI] 1.5-11.7). The gestational age at birth was higher in ataxic-hypotonic CP (median 39.0 weeks vs 37.0 weeks, p = 0.027). Children with ataxic-hypotonic CP displayed more intrauterine growth restriction (OR 2.6, 95% CI 1.0-6.8) and congenital malformation (OR 2.4, 95% CI 1.2-4.8). MRI was more likely to be either normal (OR 3.8, 95% CI 1.4-10.5) or to show a cerebral malformation (OR 4.2, 95% CI 1.5-11.9) in ataxic-hypotonic CP. There was no significant difference in terms of GMFCS or the presence of comorbidities, except for more frequent communication impairment in ataxic-hypotonic CP (OR 4.2, 95% CI 1.5-11.6). CONCLUSIONS: Our results suggest a predominantly genetic or prenatal etiology for ataxic-hypotonic CP and imply that a diagnosis of ataxic-hypotonic CP does not impart a worse prognosis with respect to comorbidities or functional impairment. This study contributes toward a better understanding of ataxic-hypotonic CP as a distinct nosologic entity within the spectrum of CP with its own pathogenesis, risk factors, clinical profile, and prognosis compared with other CP subtypes.
OBJECTIVE: To specifically report on ataxic-hypotonic cerebral palsy (CP) using registry data and to directly compare its features with other CP subtypes. METHODS: Data on prenatal, perinatal, and neonatal characteristics and gross motor function (Gross Motor Function Classification System [GMFCS]) and comorbidities in 35 children with ataxic-hypotonic CP were extracted from the Canadian Cerebral Palsy Registry and compared with 1,804 patients with other subtypes of CP. RESULTS: Perinatal adversity was detected significantly more frequently in other subtypes of CP (odds ratio [OR] 4.3, 95% confidence interval [CI] 1.5-11.7). The gestational age at birth was higher in ataxic-hypotonic CP (median 39.0 weeks vs 37.0 weeks, p = 0.027). Children with ataxic-hypotonic CP displayed more intrauterine growth restriction (OR 2.6, 95% CI 1.0-6.8) and congenital malformation (OR 2.4, 95% CI 1.2-4.8). MRI was more likely to be either normal (OR 3.8, 95% CI 1.4-10.5) or to show a cerebral malformation (OR 4.2, 95% CI 1.5-11.9) in ataxic-hypotonic CP. There was no significant difference in terms of GMFCS or the presence of comorbidities, except for more frequent communication impairment in ataxic-hypotonic CP (OR 4.2, 95% CI 1.5-11.6). CONCLUSIONS: Our results suggest a predominantly genetic or prenatal etiology for ataxic-hypotonic CP and imply that a diagnosis of ataxic-hypotonic CP does not impart a worse prognosis with respect to comorbidities or functional impairment. This study contributes toward a better understanding of ataxic-hypotonic CP as a distinct nosologic entity within the spectrum of CP with its own pathogenesis, risk factors, clinical profile, and prognosis compared with other CP subtypes.
Authors: Rilla E Schneider; Pamela Ng; Xun Zhang; John Andersen; David Buckley; Darcy Fehlings; Adam Kirton; Ellen Wood; Esias van Rensburg; Michael I Shevell; Maryam Oskoui Journal: Pediatr Neurol Date: 2018-02-12 Impact factor: 3.372
Authors: Peter Mariën; Herman Ackermann; Michael Adamaszek; Caroline H S Barwood; Alan Beaton; John Desmond; Elke De Witte; Angela J Fawcett; Ingo Hertrich; Michael Küper; Maria Leggio; Cherie Marvel; Marco Molinari; Bruce E Murdoch; Roderick I Nicolson; Jeremy D Schmahmann; Catherine J Stoodley; Markus Thürling; Dagmar Timmann; Ellen Wouters; Wolfram Ziegler Journal: Cerebellum Date: 2014-06 Impact factor: 3.847
Authors: H Eggink; D Kremer; O F Brouwer; M F Contarino; M E van Egmond; A Elema; K Folmer; J F van Hoorn; L A van de Pol; V Roelfsema; M A J Tijssen Journal: Eur J Paediatr Neurol Date: 2017-05-09 Impact factor: 3.140
Authors: Martin Bax; Murray Goldstein; Peter Rosenbaum; Alan Leviton; Nigel Paneth; Bernard Dan; Bo Jacobsson; Diane Damiano Journal: Dev Med Child Neurol Date: 2005-08 Impact factor: 5.449
Authors: Ricardo Parolin Schnekenberg; Emma M Perkins; Jack W Miller; Wayne I L Davies; Maria Cristina D'Adamo; Mauro Pessia; Katherine A Fawcett; David Sims; Elodie Gillard; Karl Hudspith; Paul Skehel; Jonathan Williams; Mary O'Regan; Sandeep Jayawant; Rosalind Jefferson; Sarah Hughes; Andrea Lustenberger; Jiannis Ragoussis; Mandy Jackson; Stephen J Tucker; Andrea H Németh Journal: Brain Date: 2015-05-16 Impact factor: 13.501
Authors: Bhooma R Aravamuthan; Darcy Fehlings; Sheetal Shetty; Michael Fahey; Laura Gilbert; Ann Tilton; Michael C Kruer Journal: Pediatrics Date: 2021-01-05 Impact factor: 7.124
Authors: Siddharth Srivastava; Erica L Macke; Lindsay C Swanson; David Coulter; Eric W Klee; Sureni V Mullegama; Yili Xie; Brendan C Lanpher; Emma C Bedoukian; Cara M Skraban; Laurent Villard; Mathieu Milh; Mary L O Leppert; Julie S Cohen Journal: Brain Sci Date: 2021-07-14